Table 2.
Time interval | Variable | Trigger for diagnosisa | p value | ||
---|---|---|---|---|---|
Family history | Newborn screening | Clinical illnessb | |||
1982–2018 | Total patients (n) | 257 | 130 | 505 | |
Infection status at HCT, n (%) | <0·001 | ||||
Infected/Active | 62 (24·1) | 27 (20·8) | 284 (56·2) | ||
Infected/Resolved | 57 (22·2) | 17 (13·1) | 146 (28·9) | ||
Infected/Unknownc | 5 (1·9) | 0 (0·0) | 18 (3·6) | ||
No infection | 133 (51·8) | 86 (66·2) | 56 (11·1) | ||
Unknown | 0 (0·0) | 0 (0·0) | 1 (0·2) | ||
Age at HCT – actual | |||||
Days of life, median (IQR) | 67·0 (29·0–151·0) | 92·5 (67·0–114·0) | 222·0 (167·0–311·0) | <0·001 | |
Age at HCT – categorical n (%) | |||||
<3·5 months old | 161 (62·6) | 87 (66·9) | 42 (8·3) | <0·001 | |
≥3·5 months old | 96 (37·4) | 43 (33·1) | 463 (91·7) | ||
2010–2018 | Total patients (n) | 49 | 130 | 89 | |
Infection status at HCT, n (%) | |||||
Infected/Active | 6 (12·2) | 27 (20·8) | 49 (55·1) | <0·001 | |
Infected/Resolved | 11 (22·5) | 17 (13·1) | 24 (27·0) | ||
Infected/Unknownc | 0 (0·0) | 0 (0·0) | 1 (1·1) | ||
No Infection | 32 (65·3) | 86 (66·1) | 14 (15·7) | ||
Unknown | 0 (0·0) | 0 (0·0) | 1 (1·1) | ||
Age at HCT – actual | |||||
Days of life, median (IQR) | 76·0 (49·0–132·0) | 92·5 (67·0–114·0) | 252·0 (152·0–461·0) | <0·001 | |
Age at HCT – categorical, n (%) | |||||
<3·5 months old | 31 (63·3) | 87 (66·9) | 8 (9·0) | <0·001 | |
≥3·5 months old | 18 (36·7) | 43 (33·1) | 81 (91·0) |
Infection status at HCT was evaluated based on trigger for diagnosis, with a sub-analysis (2010–2018) for the era when NBS became available.
Ten patients had an unknown single trigger for diagnosis identified and are therefore excluded from this analysis.
Typically related to infections, autoimmunity, and/or failure to thrive.
An infection pre-HCT was documented, but whether it was still active or had resolved at time of HCT was not recorded.
Abbreviations: FH, family history; IQR, interquartile range; NBS, newborn screening